Survivors at Risk: Hodgkin Lymphoma Survivors at High Risk of Second Cancers

Amit Sud

doi:10.2217/ijh-2017-0008

Abstract

Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University of Manchester, gaining an honors degree. He completed his Masters in Medical Research at Manchester University, gaining a distinction. He continued his medical training in Manchester and London and started his specialization in Hematology in South West London. He was successful in obtaining a Cancer Research UK funded clinical research fellowship in Hematology under the supervision of Professor Richard Houlston at the Institute of Cancer Research. His current research focus is that of genetic susceptibility to Hodgkin lymphoma. He is a trainee member of the NCRI Lymphoma Clinical Studies Group.

Highlights

QQ Could you please provide a brief summary of your career to date? I completed my undergraduate medical training at Manchester University (Manchester, UK) and spent an extra year undertaking a masters in medical research
QQ You were an author on a recent study demonstrating that Hodgkin lymphoma survivors are at high risk of secondary cancers: could you give our readers an outline of the study & its methodology? Hodgkin lymphoma was one of the first cancers that the medical profession managed to obtain relatively high cure rates through treatment involving chemotherapy and radiotherapy [1]
In terms of second cancers, the excess risk observed in Hodgkin lymphoma survivors has been reported to be influenced by various factors including age of treatment, site and dose of radiotherapy, chemotherapy and smoking [3,4,5,6,7,8,9,10]

Summary

Introduction

QQ Could you please provide a brief summary of your career to date? I completed my undergraduate medical training at Manchester University (Manchester, UK) and spent an extra year undertaking a masters in medical research. What became apparent is that many patients who survived the Hodgkin lymphoma had a lot of long-term significant complications such as second cancers and cardiovascular disease [2]. In terms of second cancers, the excess risk observed in Hodgkin lymphoma survivors has been reported to be influenced by various factors including age of treatment, site and dose of radiotherapy, chemotherapy and smoking [3,4,5,6,7,8,9,10].

Results

Conclusion